PSECX
Price
$17.04
Change
+$0.26 (+1.55%)
Updated
Apr 11 closing price
Net Assets
29.97M
VVIAX
Price
$63.18
Change
+$0.94 (+1.51%)
Updated
Apr 11 closing price
Net Assets
190.51B
Ad is loading...

PSECX vs VVIAX

Header iconPSECX vs VVIAX Comparison
Open Charts PSECX vs VVIAXBanner chart's image
1789 Growth and Income C
Price$17.04
Change+$0.26 (+1.55%)
VolumeN/A
Net Assets29.97M
Vanguard Value Index Adm
Price$63.18
Change+$0.94 (+1.51%)
VolumeN/A
Net Assets190.51B
PSECX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PSECX vs. VVIAX commentary
Apr 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSECX is a StrongBuy and VVIAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 191B vs. PSECX (30M). VVIAX pays higher dividends than PSECX: VVIAX (2.26) vs PSECX (0.48). PSECX was incepted earlier than VVIAX: PSECX (14 years) vs VVIAX (24 years). PSECX (2.03) is less costly to investors than VVIAX (0.05). PSECX is a more actively managed with annual turnover of: 20.00 vs. VVIAX (10.00). PSECX has a lower initial minimum investment than VVIAX: PSECX (2000) vs VVIAX (3000). PSECX annual gain was more profitable for investors over the last year : 2.84 vs. VVIAX (2.23). VVIAX return over 5 years is better than : 66.76 vs. PSECX (44.56).
PSECXVVIAXPSECX / VVIAX
Total Expense Ratio2.030.054,060%
Annual Report Gross Expense Ratio2.030.054,060%
Fund Existence14 years24 years-
Gain YTD-3.565-4.30483%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets30M191B0%
Annual Yield % from dividends0.482.2621%
Returns for 1 year2.842.23128%
Returns for 3 years4.369.7545%
Returns for 5 years44.5666.7667%
Returns for 10 years41.0091.4745%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLSI9.860.54
+5.79%
Greenwich LifeSciences
XERS4.160.21
+5.32%
Xeris Biopharma Holdings
AOS64.501.63
+2.59%
AO Smith Corp
ATMU33.15-0.47
-1.40%
Atmus Filtration Technologies
MRIN0.51-0.12
-18.71%
Marin Software